Begg CB - Search Results

1

Screening for cutaneous melanoma by skin self-examination.

Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Berwick M, et al. Among authors: begg cb. J Natl Cancer Inst. 1996 Jan 3;88(1):17-23. doi: 10.1093/jnci/88.1.17. J Natl Cancer Inst. 1996. PMID: 8847720

2

Prognostic factors in differentiated carcinoma of the thyroid gland.

Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Shah JP, et al. Am J Surg. 1992 Dec;164(6):658-61. doi: 10.1016/s0002-9610(05)80729-9. Am J Surg. 1992. PMID: 1463119

3

The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation.

Fuks Z, Leibel SA, Wallner KE, Begg CB, Fair WR, Anderson LL, Hilaris BS, Whitmore WF. Fuks Z, et al. Among authors: begg cb. Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):537-47. doi: 10.1016/0360-3016(91)90668-t. Int J Radiat Oncol Biol Phys. 1991. PMID: 1869452

4

Suspended judgment. Significance tests of covariate imbalance in clinical trials.

Begg CB. Begg CB. Control Clin Trials. 1990 Aug;11(4):223-5. doi: 10.1016/0197-2456(90)90037-3. Control Clin Trials. 1990. PMID: 2171874 No abstract available.

5

Consensus diagnoses and "gold standards".

Begg CB, Metz CE. Begg CB, et al. Med Decis Making. 1990 Jan-Mar;10(1):29-30. doi: 10.1177/0272989X9001000106. Med Decis Making. 1990. PMID: 2182961 No abstract available.

6

Publication bias and dissemination of clinical research.

Begg CB, Berlin JA. Begg CB, et al. J Natl Cancer Inst. 1989 Jan 18;81(2):107-15. doi: 10.1093/jnci/81.2.107. J Natl Cancer Inst. 1989. PMID: 2642556

7

State of the art in comparative cancer clinical trials.

Begg CB, Pocock SJ, Freedman L, Zelen M. Begg CB, et al. Cancer. 1987 Dec 1;60(11):2811-5. doi: 10.1002/1097-0142(19871201)60:11<2811::aid-cncr2820601136>3.0.co;2-p. Cancer. 1987. PMID: 3315175 Review.

8

Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin.

Schultz PK, Kelly WK, Begg C, Liebertz C, Cohen L, Scher HI. Schultz PK, et al. Urology. 1994 Aug;44(2):237-42. doi: 10.1016/s0090-4295(94)80138-x. Urology. 1994. PMID: 7519382 Clinical Trial.

9

Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program.

Begg CB, Zhang ZF, Sun M, Herr HW, Schantz SP. Begg CB, et al. Am J Epidemiol. 1995 Sep 15;142(6):653-65. doi: 10.1093/oxfordjournals.aje.a117689. Am J Epidemiol. 1995. PMID: 7653476

10

Risk factors and p53 nuclear overexpression in early stage intestinal-type adenocarcinoma of the stomach.

Zhang ZF, Karpeh MS, Lauwers GY, Marrero AM, Pollack D, Cordon-Cardo C, Begg C. Zhang ZF, et al. Cancer Detect Prev. 1995;19(2):156-64. Cancer Detect Prev. 1995. PMID: 7750103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results